Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microfilament motor activity	MYH10 MYO1E MYO7A MYO7B MYO10	3.09e-06	38	120	5	GO:0000146
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH10 MYO1E MYO7A MYO7B DYNC2H1 MYO10 DYNC1H1	7.21e-06	118	120	7	GO:0003774
GeneOntologyCellularComponent	myosin complex	MYH10 MYO1E MYO7A MYO7B MYO10	1.98e-05	59	117	5	GO:0016459
Domain	Myosin_head_motor_dom	MYH10 MYO1E MYO7A MYO7B MYO10	4.09e-06	38	119	5	IPR001609
Domain	MYOSIN_MOTOR	MYH10 MYO1E MYO7A MYO7B MYO10	4.09e-06	38	119	5	PS51456
Domain	Myosin_head	MYH10 MYO1E MYO7A MYO7B MYO10	4.09e-06	38	119	5	PF00063
Domain	MYSc	MYH10 MYO1E MYO7A MYO7B MYO10	4.09e-06	38	119	5	SM00242
Domain	MYTH4	MYO7A MYO7B MYO10	2.06e-05	9	119	3	PS51016
Domain	MyTH4	MYO7A MYO7B MYO10	2.06e-05	9	119	3	SM00139
Domain	MyTH4_dom	MYO7A MYO7B MYO10	2.06e-05	9	119	3	IPR000857
Domain	MyTH4	MYO7A MYO7B MYO10	2.06e-05	9	119	3	PF00784
Domain	-	SDK2 LRFN1 MXRA5 DSCAM HLA-DQA1 GBE1 PKHD1L1 BTN3A1 BTN2A1 PKHD1 ASTN1 EGFLAM ALPK2 EPHA7	8.36e-05	663	119	14	2.60.40.10
Domain	IQ	MYH10 MYO1E MYO7A MYO7B MYO10	8.98e-05	71	119	5	PF00612
Domain	PRY	BTN3A1 BTN2A1 TRIM16 TRIM38	1.45e-04	42	119	4	PF13765
Domain	Ig-like_fold	SDK2 LRFN1 MXRA5 DSCAM HLA-DQA1 GBE1 PKHD1L1 BTN3A1 BTN2A1 PKHD1 ASTN1 EGFLAM ALPK2 EPHA7	1.61e-04	706	119	14	IPR013783
Domain	G8_domain	PKHD1L1 PKHD1	2.40e-04	4	119	2	IPR019316
Domain	G8	PKHD1L1 PKHD1	2.40e-04	4	119	2	PS51484
Domain	G8	PKHD1L1 PKHD1	2.40e-04	4	119	2	SM01225
Domain	G8	PKHD1L1 PKHD1	2.40e-04	4	119	2	PF10162
Domain	PRY	BTN3A1 BTN2A1 TRIM16 TRIM38	2.45e-04	48	119	4	SM00589
Domain	PRY	BTN3A1 BTN2A1 TRIM16 TRIM38	2.45e-04	48	119	4	IPR006574
Domain	IQ_motif_EF-hand-BS	MYH10 MYO1E MYO7A MYO7B MYO10	2.75e-04	90	119	5	IPR000048
Domain	IQ	MYH10 MYO1E MYO7A MYO7B MYO10	3.21e-04	93	119	5	PS50096
Domain	Cupredoxin	TMED6 PRPF8 PKHD1L1	3.56e-04	22	119	3	IPR008972
Domain	ConA-like_dom	FAT3 BTN3A1 BTN2A1 TRIM16 NELL2 EGFLAM TRIM38	5.11e-04	219	119	7	IPR013320
Domain	Ig_E-set	VPS26C GBE1 PKHD1L1 NXPE3 PKHD1	5.37e-04	104	119	5	IPR014756
Domain	PbH1	PKHD1L1 PKHD1	5.94e-04	6	119	2	SM00710
Domain	ITI_HC_C	ITIH4 ITIH5	5.94e-04	6	119	2	IPR010600
Domain	PbH1	PKHD1L1 PKHD1	5.94e-04	6	119	2	IPR006626
Domain	ITI_HC_C	ITIH4 ITIH5	5.94e-04	6	119	2	PF06668
Domain	Butyrophylin	BTN3A1 BTN2A1 TRIM16 TRIM38	1.04e-03	70	119	4	IPR003879
Domain	DHC_N1	DYNC2H1 DYNC1H1	1.10e-03	8	119	2	PF08385
Domain	Pectin_lyase_fold/virulence	PKHD1L1 PKHD1	1.10e-03	8	119	2	IPR011050
Domain	VIT	ITIH4 ITIH5	1.10e-03	8	119	2	PF08487
Domain	VIT	ITIH4 ITIH5	1.10e-03	8	119	2	SM00609
Domain	Dynein_heavy_dom-1	DYNC2H1 DYNC1H1	1.10e-03	8	119	2	IPR013594
Domain	FN3	SDK2 LRFN1 DSCAM ASTN1 EGFLAM EPHA7	1.20e-03	185	119	6	SM00060
Domain	Ptc/Disp	PTCHD1 PTCH2	1.41e-03	9	119	2	IPR003392
Domain	Patched	PTCHD1 PTCH2	1.41e-03	9	119	2	PF02460
Domain	EGF-like_CS	FAT3 NELL2 TENM3 C1S ASTN1 EGFLAM EPHA7	1.42e-03	261	119	7	IPR013032
Domain	EGF_2	FAT3 NELL2 TENM3 C1S ASTN1 EGFLAM EPHA7	1.55e-03	265	119	7	PS01186
Domain	FN3	SDK2 LRFN1 DSCAM ASTN1 EGFLAM EPHA7	1.74e-03	199	119	6	PS50853
Domain	VIT	ITIH4 ITIH5	1.75e-03	10	119	2	PS51468
Domain	VIT	ITIH4 ITIH5	1.75e-03	10	119	2	IPR013694
Domain	IQ	MYH10 MYO7A MYO7B MYO10	1.79e-03	81	119	4	SM00015
Domain	Laminin_G_2	FAT3 NELL2 EGFLAM	2.10e-03	40	119	3	PF02210
Domain	FN3_dom	SDK2 LRFN1 DSCAM ASTN1 EGFLAM EPHA7	2.22e-03	209	119	6	IPR003961
Domain	SPRY	BTN3A1 BTN2A1 TRIM16 TRIM38	2.32e-03	87	119	4	SM00449
Domain	LamG	FAT3 NELL2 EGFLAM	2.76e-03	44	119	3	SM00282
Domain	EF-hand_1	FKBP10 CAPS FKBP9 DGKA EFHC2	2.90e-03	152	119	5	PF00036
Domain	SSD	PTCHD1 PTCH2	3.00e-03	13	119	2	IPR000731
Domain	SSD	PTCHD1 PTCH2	3.00e-03	13	119	2	PS50156
Domain	PP2Ac	PPP2CA PPP2CB	3.00e-03	13	119	2	SM00156
Domain	Ser/Thr-sp_prot-phosphatase	PPP2CA PPP2CB	3.00e-03	13	119	2	IPR006186
Domain	SER_THR_PHOSPHATASE	PPP2CA PPP2CB	3.00e-03	13	119	2	PS00125
Domain	SPRY	BTN3A1 BTN2A1 TRIM16 TRIM38	3.07e-03	94	119	4	PF00622
Domain	SPRY_dom	BTN3A1 BTN2A1 TRIM16 TRIM38	3.07e-03	94	119	4	IPR003877
Domain	FERM_M	MYO7A MYO7B MYO10	3.14e-03	46	119	3	PF00373
Domain	B30.2/SPRY	BTN3A1 BTN2A1 TRIM16 TRIM38	3.19e-03	95	119	4	IPR001870
Domain	B302_SPRY	BTN3A1 BTN2A1 TRIM16 TRIM38	3.19e-03	95	119	4	PS50188
Domain	ER_TARGET	FKBP10 FKBP9 PDIA5	3.33e-03	47	119	3	PS00014
Domain	EFh	FKBP10 EFCAB11 CAPS FKBP9 DGKA	3.43e-03	158	119	5	SM00054
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DYNC1H1	3.48e-03	14	119	2	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DYNC1H1	3.48e-03	14	119	2	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DYNC1H1	3.48e-03	14	119	2	IPR013602
Domain	DHC_N2	DYNC2H1 DYNC1H1	3.48e-03	14	119	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DYNC1H1	3.48e-03	14	119	2	IPR011704
Domain	MT	DYNC2H1 DYNC1H1	3.48e-03	14	119	2	PF12777
Domain	AAA_8	DYNC2H1 DYNC1H1	3.48e-03	14	119	2	PF12780
Domain	AAA_5	DYNC2H1 DYNC1H1	3.48e-03	14	119	2	PF07728
Domain	EF_HAND_2	FKBP10 EFCAB11 CAPS FKBP9 DGKA EFHC2	3.65e-03	231	119	6	PS50222
Domain	EF_hand_dom	FKBP10 EFCAB11 CAPS FKBP9 DGKA EFHC2	3.73e-03	232	119	6	IPR002048
Domain	-	MYO7A MYO7B MYO10	3.75e-03	49	119	3	1.20.80.10
Domain	FERM_central	MYO7A MYO7B MYO10	3.75e-03	49	119	3	IPR019748
Domain	FERM_domain	MYO7A MYO7B MYO10	3.75e-03	49	119	3	IPR000299
Domain	fn3	SDK2 LRFN1 DSCAM EGFLAM EPHA7	3.81e-03	162	119	5	PF00041
Domain	EGF_3	FAT3 NELL2 TENM3 C1S ASTN1 EGFLAM	3.97e-03	235	119	6	PS50026
Domain	FERM/acyl-CoA-bd_prot_3-hlx	MYO7A MYO7B MYO10	3.97e-03	50	119	3	IPR014352
Domain	FERM_1	MYO7A MYO7B MYO10	3.97e-03	50	119	3	PS00660
Domain	FERM_2	MYO7A MYO7B MYO10	3.97e-03	50	119	3	PS00661
Domain	FERM_3	MYO7A MYO7B MYO10	3.97e-03	50	119	3	PS50057
Domain	Band_41_domain	MYO7A MYO7B MYO10	3.97e-03	50	119	3	IPR019749
Domain	B41	MYO7A MYO7B MYO10	3.97e-03	50	119	3	SM00295
Domain	DHC_fam	DYNC2H1 DYNC1H1	4.00e-03	15	119	2	IPR026983
Domain	Dynein_heavy	DYNC2H1 DYNC1H1	4.00e-03	15	119	2	PF03028
Domain	Dynein_heavy_dom	DYNC2H1 DYNC1H1	4.00e-03	15	119	2	IPR004273
Domain	FKBP_PPIASE	FKBP10 FKBP9	4.56e-03	16	119	2	PS50059
Domain	FKBP_C	FKBP10 FKBP9	4.56e-03	16	119	2	PF00254
Domain	PPIase_FKBP	FKBP10 FKBP9	5.14e-03	17	119	2	IPR023566
Domain	EGF-like_dom	FAT3 NELL2 TENM3 C1S ASTN1 EGFLAM	5.24e-03	249	119	6	IPR000742
Domain	EF_Hand_1_Ca_BS	FKBP10 EFCAB11 CAPS FKBP9 DGKA	5.28e-03	175	119	5	IPR018247
Domain	VWA	VIT ITIH4 ITIH5	5.47e-03	56	119	3	PF00092
Domain	EGF_1	FAT3 NELL2 TENM3 C1S ASTN1 EGFLAM	5.88e-03	255	119	6	PS00022
Domain	Laminin_G	FAT3 NELL2 EGFLAM	6.03e-03	58	119	3	IPR001791
Pathway	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1	PPP2CA PPP2CB PRIM1	2.46e-05	10	85	3	MM14509
Pathway	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1	PPP2CA PPP2CB PRIM1	5.79e-05	13	85	3	M1015
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	FKBP10 RPN1 DYNC2H1 FLVCR1 C1orf43 UBR4 PRPF8 DDOST NDUFV1 WDR19 NBAS SF3B3 CASKIN2 DNAJC5G MRPS6 SLC39A6 PDIA5 TTC17 SCFD1 VPS13B EPHA7	3.79e-08	1487	120	21	33957083
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	MYH10 UBR4 SMC6 GBE1 PPP2CA PPP2CB CST4 TTC17 SCFD1	1.18e-06	304	120	9	32235678
Pubmed	Tails of unconventional myosins.	MYO7A MYO7B MYO10	1.39e-06	7	120	3	11212352
Pubmed	PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum.	PPP2CA PPP2CB ATP6V0D2	1.12e-05	13	120	3	16717086
Pubmed	Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy.	B4GALT2 TNF	1.18e-05	2	120	2	15504978
Pubmed	Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A.	PPP2CA PPP2CB	1.18e-05	2	120	2	2555176
Pubmed	Mechanisms underlying Myosin 10's contribution to the maintenance of mitotic spindle bipolarity.	MYH10 MYO10	1.18e-05	2	120	2	38019611
Pubmed	Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.	BTN3A1 BTN2A1	1.18e-05	2	120	2	37674084
Pubmed	TMC7 functions as a suppressor of Piezo2 in primary sensory neurons blunting peripheral mechanotransduction.	TMC7 PIEZO2	1.18e-05	2	120	2	38568807
Pubmed	Regulation of spindle formation by active mitogen-activated protein kinase and protein phosphatase 2A during mouse oocyte meiosis.	PPP2CA PPP2CB	1.18e-05	2	120	2	11751260
Pubmed	Genetic analysis of the cytoplasmic dynein subunit families.	DYNC2H1 DYNC1H1	1.18e-05	2	120	2	16440056
Pubmed	Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart.	PPP2CA PPP2CB	1.18e-05	2	120	2	11113010
Pubmed	The role of protein phosphatase 2A catalytic subunit Calpha in embryogenesis: evidence from sequence analysis and localization studies.	PPP2CA PPP2CB	1.18e-05	2	120	2	10543450
Pubmed	Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.	BTN3A1 BTN2A1	1.18e-05	2	120	2	35081362
Pubmed	Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.	HLA-DQA1 TNF	1.18e-05	2	120	2	18240225
Pubmed	Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities.	PPP2CA PPP2CB	1.18e-05	2	120	2	34902541
Pubmed	Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes.	PPP2CA PPP2CB	1.18e-05	2	120	2	2837763
Pubmed	Inhibition of microtubules and dynein rescues human immunodeficiency virus type 1 from owl monkey TRIMCyp-mediated restriction in a cellular context-specific fashion.	DYNC2H1 DYNC1H1	1.18e-05	2	120	2	25502651
Pubmed	Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes.	PPP2CA PPP2CB	1.18e-05	2	120	2	1846293
Pubmed	PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte.	PPP2CA PPP2CB	1.18e-05	2	120	2	27096707
Pubmed	Mutations to the BTN2A1 Linker Region Impact Its Homodimerization and Its Cytoplasmic Interaction with Phospho-Antigen-Bound BTN3A1.	BTN3A1 BTN2A1	1.18e-05	2	120	2	37171180
Pubmed	Defective Angiogenesis and Intraretinal Bleeding in Mouse Models With Disrupted Inner Retinal Lamination.	DSCAM FAT3	1.18e-05	2	120	2	27046121
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MYH10 ZFAT MYO10 YBEY C1orf43 UBR4 SMC6 MED13L DDOST TRIM16 XYLT2 NBAS PPP2CA PTCHD1 SF3B3 SSH2	1.37e-05	1327	120	16	32694731
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYO1E MYO7A MYO7B	1.42e-05	14	120	3	8022818
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	FKBP10 MYO1E RPN1 PRPF8 DDOST NDUFV1 SF3B3 SCFD1 DYNC1H1	1.67e-05	422	120	9	27342126
Pubmed	Mapping of unconventional myosins in mouse and human.	MYO1E MYO7A MYO7B MYO10	2.33e-05	48	120	4	8884266
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SDK2 LRFN1 ZFAT TENM3 BAHCC1	3.01e-05	103	120	5	10819331
Pubmed	A 1.1-Mb transcript map of the hereditary hemochromatosis locus.	BTN3A1 BTN2A1 TRIM38	3.15e-05	18	120	3	9149941
Pubmed	Ten-m3 plays a role in the formation of thalamostriatal projections.	TENM3 EPHA7	3.53e-05	3	120	2	37700636
Pubmed	DQA1 and DQB1 association and nasal polyposis.	HLA-DQA1 TNF	3.53e-05	3	120	2	16890076
Pubmed	TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients.	HLA-DQA1 TNF	3.53e-05	3	120	2	11294926
Pubmed	Major histocompatibility locus genetic markers of beryllium sensitization and disease.	HLA-DQA1 TNF	3.53e-05	3	120	2	11716174
Pubmed	Cytoplasmic dynein promotes HIV-1 uncoating.	DYNC2H1 DYNC1H1	3.53e-05	3	120	2	25375884
Pubmed	TWEAK prevents TNF-α-induced insulin resistance through PP2A activation in human adipocytes.	PPP2CA TNF	3.53e-05	3	120	2	23651848
Pubmed	Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts.	PPP2CA PPP2CB	3.53e-05	3	120	2	7510677
Pubmed	Mammalian cells express three distinct dynein heavy chains that are localized to different cytoplasmic organelles.	DYNC2H1 DYNC1H1	3.53e-05	3	120	2	8666668
Pubmed	Interleukin-2 induces N-glycosylation in T-cells: characterization of human lymphocyte oligosaccharyltransferase.	RPN1 DDOST	3.53e-05	3	120	2	9642163
Pubmed	Both Myosin-10 isoforms are required for radial neuronal migration in the developing cerebral cortex.	MYH10 MYO10	3.53e-05	3	120	2	23300110
Pubmed	Recombinant human cytoplasmic dynein heavy chain 1 and 2: observation of dynein-2 motor activity in vitro.	DYNC2H1 DYNC1H1	3.53e-05	3	120	2	21723285
Pubmed	The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo.	PPP2CA PPP2CB	3.53e-05	3	120	2	8206937
Pubmed	Tumor necrosis factor-α impairs adiponectin signalling, mitochondrial biogenesis, and myogenesis in primary human myotubes cultures.	ADIPOR1 TNF	3.53e-05	3	120	2	26921438
Pubmed	TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ.	HLA-DQA1 TNF	3.53e-05	3	120	2	17678725
Pubmed	Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons.	GRIA1 TNF	3.53e-05	3	120	2	15869941
Pubmed	Increased levels of inositol hexakisphosphate (InsP6) protect HEK293 cells from tumor necrosis factor (alpha)- and Fas-induced apoptosis.	IPPK TNF	3.53e-05	3	120	2	15967797
Pubmed	Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans.	HLA-DQA1 TNF	3.53e-05	3	120	2	15725578
Pubmed	Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favors association with the alpha 4 subunit which promotes dephosphorylation of elongation factor-2.	PPP2CA PPP2CB	3.53e-05	3	120	2	10441131
Pubmed	Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function.	PPP2CA PPP2CB	3.53e-05	3	120	2	23341017
Pubmed	Localization of the genes encoding the catalytic subunits of protein phosphatase 2A to human chromosome bands 5q23-->q31 and 8p12-->p11.2, respectively.	PPP2CA PPP2CB	3.53e-05	3	120	2	8383590
Pubmed	Overlapping binding sites in protein phosphatase 2A for association with regulatory A and alpha-4 (mTap42) subunits.	PPP2CA PPP2CB	3.53e-05	3	120	2	15252037
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MYH10 MYO7A DYNC2H1 PRPF8 TENM3 CLK2 DYNC1H1 EPHA7	3.60e-05	358	120	8	32460013
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	IPPK MXRA5 MYO7A RPN1 YBEY UBR4 DGKA PRPF8 DDOST PKHD1 DYNC1H1	5.09e-05	736	120	11	29676528
Pubmed	Interactome of the Autoimmune Risk Protein ANKRD55.	MYH10 RPN1 PRPF8 DDOST SF3B3 DYNC1H1	6.54e-05	197	120	6	31620119
Pubmed	Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.	HLA-DQA1 TNF	7.05e-05	4	120	2	15842729
Pubmed	Developmental and hormonal regulation of the expression of oligodendrocyte-specific protein/claudin 11 in mouse testis.	CLDN11 TNF	7.05e-05	4	120	2	10919290
Pubmed	Mitotic Phosphorylation of TREX1 C Terminus Disrupts TREX1 Regulation of the Oligosaccharyltransferase Complex.	RPN1 DDOST	7.05e-05	4	120	2	28297665
Pubmed	The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation.	PPP2CA PPP2CB	7.05e-05	4	120	2	21454489
Pubmed	Cloning, localization, and structure of new members of the butyrophilin gene family in the juxta-telomeric region of the major histocompatibility complex.	BTN3A1 BTN2A1	7.05e-05	4	120	2	9382921
Pubmed	Myosin X regulates netrin receptors and functions in axonal path-finding.	MYH10 MYO10	7.05e-05	4	120	2	17237772
Pubmed	Filopodia powered by class x myosin promote fusion of mammalian myoblasts.	MYH10 MYO10	7.05e-05	4	120	2	34519272
Pubmed	Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse.	PPP2CA PPP2CB	7.05e-05	4	120	2	21998041
Pubmed	Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome.	HLA-DQA1 TNF	7.05e-05	4	120	2	11246532
Pubmed	Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain.	PPP2CA PPP2CB	7.05e-05	4	120	2	7616230
Pubmed	Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain.	PPP2CA PPP2CB	7.05e-05	4	120	2	9920888
Pubmed	Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration.	GRIA1 TNF	7.05e-05	4	120	2	20132465
Pubmed	Malectin forms a complex with ribophorin I for enhanced association with misfolded glycoproteins.	RPN1 DDOST	7.05e-05	4	120	2	22988243
Pubmed	Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.	PPP2CA PPP2CB	7.05e-05	4	120	2	11371618
Pubmed	[Frequencies of the DRB1, DQA1, DQB1 and TNFA alleles in immigrant population of West Siberia].	HLA-DQA1 TNF	7.05e-05	4	120	2	19769302
Pubmed	Vertebrate unconventional myosins.	MYO7A MYO10	7.05e-05	4	120	2	8690736
Pubmed	The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic.	PPP2CA PPP2CB	7.05e-05	4	120	2	14633983
Pubmed	Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha.	PPP2CA PPP2CB	7.05e-05	4	120	2	9770493
Pubmed	An adaptive role of TNFα in the regulation of striatal synapses.	GRIA1 TNF	7.05e-05	4	120	2	24790185
Pubmed	Adiponectin affects lung epithelial A549 cell viability counteracting TNFα and IL-1ß toxicity through AdipoR1.	ADIPOR1 TNF	7.05e-05	4	120	2	23500159
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	MYH10 DSCAM RPN1 PRPF8 SF3B3 PKHD1	7.51e-05	202	120	6	24639526
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYH10 MYO10 ALS2 MED13L TENM3 DYNC1H1 VPS13B XPO7	8.82e-05	407	120	8	12693553
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	FKBP10 RPN1 DYNC2H1 FLVCR1 C1orf43 UBR4 DDOST NDUFV1 TNF SCFD1 DYNC1H1 XPO7	1.05e-04	942	120	12	31073040
Pubmed	The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues.	BCR TNF	1.17e-04	5	120	2	10477548
Pubmed	Identification of two independent risk factors for lupus within the MHC in United Kingdom families.	HLA-DQA1 TNF	1.17e-04	5	120	2	17997607
Pubmed	[Influence of alleles and haplotypes of the main histocompatibility complex on the susceptibility to systemic lupus erythematosus in the Mexican population].	HLA-DQA1 TNF	1.17e-04	5	120	2	16875346
Pubmed	Detection of a new cerebral malaria susceptibility locus, using CBA mice.	HLA-DQA1 TNF	1.17e-04	5	120	2	15536567
Pubmed	Influenza A virus uses the aggresome processing machinery for host cell entry.	MYH10 DYNC1H1	1.17e-04	5	120	2	25342804
Pubmed	Protein Tyrosine Kinase Fyn Regulates TLR4-Elicited Responses on Mast Cells Controlling the Function of a PP2A-PKCα/β Signaling Node Leading to TNF Secretion.	PPP2CA TNF	1.17e-04	5	120	2	27183589
Pubmed	MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes.	HLA-DQA1 TNF	1.17e-04	5	120	2	12370403
Pubmed	miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A.	PPP2CB TNF	1.17e-04	5	120	2	28159925
Pubmed	Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain.	PPP2CA PPP2CB	1.17e-04	5	120	2	10640627
Pubmed	Assessment of myosin II, Va, VI and VIIa loss of function on endocytosis and endocytic vesicle motility in bone marrow-derived dendritic cells.	MYH10 MYO7A	1.17e-04	5	120	2	17615572
Pubmed	The cytoplasmic tail of fibrocystin contains a ciliary targeting sequence.	PKHD1L1 PKHD1	1.17e-04	5	120	2	20048263
Pubmed	Triplet repeat polymorphism in the transmembrane region of the MICA gene in celiac disease.	HLA-DQA1 TNF	1.17e-04	5	120	2	12074713
Pubmed	HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint.	PPP2CA PPP2CB	1.17e-04	5	120	2	9009195
Pubmed	Protein phosphatase 2A interacts with and directly dephosphorylates RelA.	PPP2CA PPP2CB	1.17e-04	5	120	2	11591705
Pubmed	Targeted disruption of the PME-1 gene causes loss of demethylated PP2A and perinatal lethality in mice.	PPP2CA PPP2CB	1.17e-04	5	120	2	18596935
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DSCAM MYO1E UBR4 VPS26C MED13L PRPF8 WDR19 NELL2 SENP6 C1S ASTN1 TTC17 GEN1 DYNC1H1	1.44e-04	1285	120	14	35914814
Pubmed	The effects of aging on gene expression in the hypothalamus and cortex of mice.	GRIA1 PPP2CA DYNC1H1 EPHA7	1.66e-04	79	120	4	11172053
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	SDK2 MYO7B FAT3 PRPF8 SF3B3 VPS13B	1.68e-04	234	120	6	36243803
Pubmed	Distinct role of protein phosphatase 2A subunit Calpha in the regulation of E-cadherin and beta-catenin during development.	PPP2CA PPP2CB	1.75e-04	6	120	2	10781942
Pubmed	Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells.	BCR TNF	1.75e-04	6	120	2	11123309
Pubmed	STRIPAK components determine mode of cancer cell migration and metastasis.	PPP2CA PPP2CB	1.75e-04	6	120	2	25531779
Pubmed	Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A.	PPP2CA PPP2CB	1.75e-04	6	120	2	20100830
Pubmed	Global loss of leucine carboxyl methyltransferase-1 causes severe defects in fetal liver hematopoiesis.	PPP2CA PPP2CB	1.75e-04	6	120	2	29735529
Pubmed	Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism.	HLA-DQA1 TNF	1.75e-04	6	120	2	15219382
Pubmed	Protein phosphorylation of human brain glutamic acid decarboxylase (GAD)65 and GAD67 and its physiological implications.	PPP2CA PPP2CB	1.75e-04	6	120	2	15147202
GeneFamily	A-kinase anchoring proteins\|Myosins, class VII\|Deafness associated genes\|FERM domain containing	MYO7A MYO7B	1.89e-05	2	79	2	1102
GeneFamily	Fibronectin type III domain containing	SDK2 LRFN1 DSCAM ASTN1 EGFLAM EPHA7	7.13e-05	160	79	6	555
GeneFamily	EF-hand domain containing	FKBP10 EFCAB11 CAPS FKBP9 DGKA EFHC2	3.93e-04	219	79	6	863
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SDK2 LRFN1 MXRA5 DSCAM ALPK2	6.97e-04	161	79	5	593
GeneFamily	Oligosaccharyltransferase complex subunits	RPN1 DDOST	1.21e-03	12	79	2	445
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO7A MYO7B MYO10	1.36e-03	50	79	3	1293
GeneFamily	Dyneins, cytoplasmic	DYNC2H1 DYNC1H1	1.43e-03	13	79	2	538
GeneFamily	Protein phosphatase catalytic subunits\|EF-hand domain containing	PPP2CA PPP2CB	1.43e-03	13	79	2	693
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTN3A1 BTN2A1	1.91e-03	15	79	2	458
GeneFamily	FKBP prolyl isomerases	FKBP10 FKBP9	2.76e-03	18	79	2	910
GeneFamily	Protein phosphatase catalytic subunits\|STRIPAK complex	PPP2CA PPP2CB	3.40e-03	20	79	2	1371
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 SDK2 MXRA5 DYNC2H1 MYO10 GRIA1 TENM3 C1S	6.47e-08	197	120	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO7B SLC2A2 TENM3 PKHD1 TRIM38 ALPK2 EPHA7	8.23e-07	189	120	7	28b502611829e4a24caff2562545c7db97686099
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MYH10 SDK2 FAT3 PIEZO2 TENM3 C1S	9.15e-07	192	120	7	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MYH10 SDK2 FAT3 PIEZO2 TENM3 C1S	9.15e-07	192	120	7	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MYH10 SDK2 MYO10 FAT3 GRIA1 PIEZO2 TENM3	9.15e-07	192	120	7	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	FKBP10 MYH10 FAT3 GRIA1 PIEZO2 TENM3 C1S	9.47e-07	193	120	7	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 SDK2 FAT3 GRIA1 PIEZO2 TENM3 C1S	9.80e-07	194	120	7	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FKBP10 SDK2 MYO10 FAT3 GRIA1 VIT TENM3	9.80e-07	194	120	7	811b382ec3da06a6bda7360abc8b633f96b2019e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 SDK2 FAT3 GRIA1 PIEZO2 TENM3 C1S	9.80e-07	194	120	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	MYH10 MYO10 FAT3 GRIA1 ITIH5 PIEZO2 TENM3	1.01e-06	195	120	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FKBP10 MYH10 FAT3 GRIA1 PIEZO2 TENM3 C1S	1.12e-06	198	120	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FKBP10 MYH10 SDK2 DYNC2H1 MYO10 TENM3 C1S	1.16e-06	199	120	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Biopsy_Other_PF-Mesenchymal-Myofibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	FKBP10 MYH10 MXRA5 ITIH5 PIEZO2 TENM3 C1S	1.20e-06	200	120	7	e504570fd7eec1524c401b1cfa9d10822d80d994
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH10 MYO10 FAT3 GRIA1 ITIH5 PIEZO2 TENM3	1.20e-06	200	120	7	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FKBP10 MYH10 MXRA5 FAT3 GRIA1 PIEZO2 C1S	1.20e-06	200	120	7	8c62f05c6042f24287a73fbdf80ff4a56f7ff403
ToppCell	Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	FKBP10 MXRA5 ITIH5 CLDN11 PIEZO2 TENM3 C1S	1.20e-06	200	120	7	d02e256b5d65a5c982ba5696bc7e077281ca3e24
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B FAT3 PKHD1L1 PKHD1 C1S ASTN1	4.81e-06	160	120	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B FAT3 PKHD1L1 PKHD1 C1S ASTN1	4.81e-06	160	120	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Basal_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CRYBG2 SDK2 LRFN1 MXRA5 EGFLAM EPHA7	4.81e-06	160	120	6	b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FKBP10 MXRA5 DYNC2H1 ITIH5 C1S EPHA7	6.59e-06	169	120	6	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	MXRA5 FAT3 CLDN11 PIEZO2 TENM3 C1S	9.75e-06	181	120	6	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2\|TCGA-Skin / Sample_Type by Project: Shred V9	C1orf43 VPS26C ADIPOR1 SLC39A6 GFM1 DYNC1H1	9.75e-06	181	120	6	9d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFAT TMC7 NELL2 CLDN11 TENM3 EGFLAM	1.01e-05	182	120	6	e3248d108b51c49ca2c978636e13017e23b53860
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B FAT3 PKHD1L1 PIEZO2 PKHD1 EPHA7	1.07e-05	184	120	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B FAT3 PKHD1L1 PIEZO2 PKHD1 EPHA7	1.07e-05	184	120	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B FAT3 PKHD1L1 PIEZO2 PKHD1 EPHA7	1.07e-05	184	120	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP42 MYO7B PKHD1 ALPK2 APBB1IP EPHA7	1.14e-05	186	120	6	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MYH10 MXRA5 MYO1E VASH1 FKBP9 CASKIN2	1.14e-05	186	120	6	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	COVID-19-kidney-Stressed_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	ARHGAP42 ZFAT MYO7B SLC2A2 ALPK2 EPHA7	1.17e-05	187	120	6	acd305475f3609800af0d7bc68d83ef41228080b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 FAT3 GRIA1 PIEZO2 TENM3 C1S	1.25e-05	189	120	6	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 SDK2 ITIH4 PIEZO2 TENM3 C1S	1.25e-05	189	120	6	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH10 DYNC2H1 MYO10 FAT3 ITIH5 PIEZO2	1.25e-05	189	120	6	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MYH10 MYO7A PKHD1L1 NELL2 PIEZO2 TENM3	1.28e-05	190	120	6	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MYH10 SDK2 PIEZO2 TENM3 C1S	1.28e-05	190	120	6	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IPPK MYO7B FKBP9 THSD1 CLDN11 CASKIN2	1.28e-05	190	120	6	d0297d678498e346e56cf95fe9e3db7d3ad3b837
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	MYH10 MYO10 FAT3 ITIH5 NELL2 PIEZO2	1.28e-05	190	120	6	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MXRA5 GRIA1 CLDN11 TENM3 ASTN1 EGFLAM	1.28e-05	190	120	6	4f775ee24b14733f06ae40b45f2dc1a0f0df0705
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARHGAP42 RPN1 PKHD1L1 DDOST PDIA5 ACOXL	1.28e-05	190	120	6	84eb7761f537d270673909a71d4f122e826769d5
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 SDK2 FAT3 PIEZO2 TENM3 C1S	1.32e-05	191	120	6	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MYH10 SDK2 PIEZO2 TENM3 C1S	1.36e-05	192	120	6	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 FAT3 GRIA1 PIEZO2 TENM3 C1S	1.36e-05	192	120	6	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	COVID-19_Severe-Lymphoid_P\|COVID-19_Severe / Disease group, lineage and cell class	ARHGAP42 RPN1 PKHD1L1 DDOST PDIA5 ACOXL	1.36e-05	192	120	6	3d0240491296757b3125f6e861bbaca06bbc5068
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MYH10 FAT3 PIEZO2 TENM3 C1S	1.36e-05	192	120	6	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	COVID-19_Severe-Lymphoid_P-Plasmablast\|COVID-19_Severe / Disease group, lineage and cell class	ARHGAP42 RPN1 PKHD1L1 DDOST PDIA5 ACOXL	1.36e-05	192	120	6	90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 SDK2 FAT3 PIEZO2 TENM3 C1S	1.36e-05	192	120	6	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTCH2 PKP2 C1S ASTN1 EGFLAM ALPK2	1.40e-05	193	120	6	c5bd0ed6f57459e54d2463318e8d9b1879718e63
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH10 SDK2 MYO10 FAT3 GRIA1 PIEZO2	1.40e-05	193	120	6	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MYH10 SDK2 MYO10 FAT3 GRIA1 PIEZO2	1.40e-05	193	120	6	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	MYH10 SDK2 MYO10 FAT3 GRIA1 PIEZO2	1.40e-05	193	120	6	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH10 SDK2 MYO10 FAT3 GRIA1 PIEZO2	1.44e-05	194	120	6	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	UBR4 TNMD PKHD1 ALPK2 APBB1IP EPHA7	1.44e-05	194	120	6	70185c0b8e0f4e896645b17a243482ba3cdf4a5d
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 MYH10 FAT3 PIEZO2 TENM3 C1S	1.44e-05	194	120	6	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FKBP10 SDK2 MYO10 FAT3 VIT TENM3	1.44e-05	194	120	6	292ce9021678534c9eedb367b9772a9d976208a8
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FKBP10 MYH10 FAT3 GRIA1 PIEZO2 C1S	1.49e-05	195	120	6	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FKBP10 MYH10 FAT3 GRIA1 PIEZO2 C1S	1.49e-05	195	120	6	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYH10 SDK2 MYO10 FAT3 ITIH5 PIEZO2	1.53e-05	196	120	6	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYH10 SDK2 MYO10 FAT3 ITIH5 PIEZO2	1.53e-05	196	120	6	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	FKBP10 MYH10 MXRA5 PIEZO2 TENM3 C1S	1.53e-05	196	120	6	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FKBP10 MYH10 FAT3 GRIA1 PIEZO2 C1S	1.53e-05	196	120	6	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	FKBP10 MYH10 MXRA5 PIEZO2 TENM3 C1S	1.58e-05	197	120	6	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FKBP10 MXRA5 MYO1E DYNC2H1 FKBP9 EGFLAM	1.58e-05	197	120	6	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MXRA5 CLDN11 TENM3 C1S EGFLAM ZNF287	1.58e-05	197	120	6	31c8d6e565bbdc37843ce871fe91845b0cc18a9f
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	FKBP10 MYH10 FAT3 GRIA1 PIEZO2 C1S	1.58e-05	197	120	6	6c57ab2efb8363828e24211c4d45e58bb73a9a4d
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-AT1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ZFAT FAT3 ITIH5 TENM3 ATP6V0D2 BAHCC1	1.58e-05	197	120	6	f7ef62d78336812573148f8bfce401877ec4e29c
ToppCell	control-B_intermediate\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-DQA1 SMC6 PKHD1L1 FAM111B PTCHD1 GEN1	1.62e-05	198	120	6	e24345c8cec8c21f7b5163b7326ba8f83a587ce3
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ARHGAP42 FKBP10 MYH10 FAT3 PIEZO2 TENM3	1.62e-05	198	120	6	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FKBP10 MYH10 SDK2 MXRA5 TENM3 C1S	1.67e-05	199	120	6	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast\|COVID-19_Severe / Disease, condition lineage and cell class	ARHGAP42 RPN1 PKHD1L1 DDOST PDIA5 ACOXL	1.67e-05	199	120	6	e6422b65e22e5aa8dfaebdae5be76dd78b978604
ToppCell	metastatic_Brain-Fibroblasts-FB-like_cells\|metastatic_Brain / Location, Cell class and cell subclass	FKBP10 MXRA5 CLDN11 PIEZO2 BPI C1S	1.67e-05	199	120	6	12133087eae9f0e9b6c13a71e8187117768e64ce
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FKBP10 MYH10 SDK2 MXRA5 TENM3 C1S	1.67e-05	199	120	6	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	Fibroblasts\|World / lung cells shred on cell class, cell subclass, sample id	FKBP10 MYH10 MXRA5 PIEZO2 TENM3 C1S	1.67e-05	199	120	6	e2b6752fcabd5249a166486ae6796f2c97c1fcaf
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	MYH10 SDK2 MYO10 ITIH5 TENM3 C1S	1.67e-05	199	120	6	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYH10 SDK2 DYNC2H1 MYO10 ITIH5 C1S	1.67e-05	199	120	6	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYH10 SDK2 MXRA5 GBE1 TENM3 C1S	1.67e-05	199	120	6	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	MYH10 SDK2 MYO10 ITIH5 TENM3 C1S	1.67e-05	199	120	6	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MYH10 SDK2 FAT3 GRIA1 PIEZO2 C1S	1.72e-05	200	120	6	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ZFAT DSCAM CLDN11 PRIM1 EGFLAM XPO7	1.72e-05	200	120	6	24e13b6d9d2d8b29df1f02544ea9c50084d9e75c
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYH10 SDK2 FAT3 GRIA1 PIEZO2 C1S	1.72e-05	200	120	6	a510deaada669e690329183e18df02870bd204b3
ToppCell	Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DSCAM CLDN11 PRIM1 C1S EGFLAM XPO7	1.72e-05	200	120	6	f7c3a8f5ac156c05ad7335d6d142c154c7d86449
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Unfolded_protein_responsible_cell\|5w / Sample Type, Dataset, Time_group, and Cell type.	C1orf43 PUSL1 VPS26C ADIPOR1 TGDS PDIA5	1.72e-05	200	120	6	fa6a0f859fbf2d97d5849107290d578a44a88d7e
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FKBP10 MYH10 FAT3 GRIA1 PIEZO2 C1S	1.72e-05	200	120	6	cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYH10 SDK2 DYNC2H1 MYO10 ITIH5 C1S	1.72e-05	200	120	6	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FKBP10 MYH10 MXRA5 PIEZO2 TENM3 C1S	1.72e-05	200	120	6	54806080b5e97859ee6a4a9b4f19e22021c218f5
ToppCell	Biopsy_IPF-Mesenchymal-Myofibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	FKBP10 MYH10 MXRA5 ITIH5 PIEZO2 C1S	1.72e-05	200	120	6	c2c6f687c49ba790174b27c7b8b084af30b34c86
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYH10 SDK2 FAT3 GRIA1 PIEZO2 C1S	1.72e-05	200	120	6	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYNC2H1 FAT3 LCT ATP6V0D2 DMBT1	6.90e-05	158	120	5	12661763d1c309106801cb710c04cd2b62d16cba
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYNC2H1 FAT3 LCT ATP6V0D2 DMBT1	6.90e-05	158	120	5	e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYNC2H1 FAT3 LCT ATP6V0D2 DMBT1	6.90e-05	158	120	5	0792c39e6fc0745095af7812de2d50949540d60f
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FAT3 PKHD1L1 PKHD1 ATP6V0D2 DMBT1	7.77e-05	162	120	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	B4GALT2 ARHGAP42 ZFAT PKHD1L1 PDIA5	7.77e-05	162	120	5	8278dccdb139396ede34b83b02ebce837f2489d6
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	DSCAM CATSPERD NELL2 PIEZO2 EGFLAM	7.99e-05	163	120	5	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	Endothelial-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	FKBP10 THSD1 PKHD1L1 CLDN11 PIEZO2	8.47e-05	165	120	5	10087d8bd2985906ef19547fe77eb178ae5e1638
ToppCell	droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HLA-DQA1 FLVCR1 SF3B3 PDIA5 BAHCC1	8.47e-05	165	120	5	1d0f60bf47a40ac916f0fcb5532a968742a0edbb
ToppCell	droplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC7A13 ALS2 PTCHD1 ATP6V0D2 EPHA7	8.71e-05	166	120	5	35db3022c33d6f8bb6587d9eec89a7cccb70271a
ToppCell	Endothelial-B-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	THSD1 PKHD1L1 CLDN11 PIEZO2 TENM3	9.48e-05	169	120	5	95c617143e1fbdd1d55a93ffdcc210e0be37cf2f
ToppCell	(7)_MNP-(7)_DC_activated\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	FAT3 CHKB NELL2 PIEZO2 ALPK2	9.74e-05	170	120	5	4ab495b38a071fa8207331df2ce0d78a2dcd034e
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITIH5 CST4 PTCH2 C1S ALPK2	9.74e-05	170	120	5	7653f1205d4e62abe7e31b1d76f9bbd665e45667
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 SMC6 ESRP1 PEBP4 GEN1	1.00e-04	171	120	5	a2938e56cb5749004317798dc7ac0f0c2d4d8ae0
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 PTCH2 PKP2 GEN1 EPHA7	1.03e-04	172	120	5	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 PTCH2 PKP2 GEN1 EPHA7	1.03e-04	172	120	5	6ab4f01098dddb789df298ddf97b3c384405ee6c
Disease	Ciliopathies	MYO7A DYNC2H1 CEP164 WDR19 PKHD1	7.58e-05	110	116	5	C4277690
Disease	Jeune thoracic dystrophy	DYNC2H1 WDR19	9.15e-05	4	116	2	cv:C0265275
Disease	Scleroderma	XYLT2 TNF	9.15e-05	4	116	2	C0011644
Disease	matrilysin measurement	ARHGAP42 MMP20	1.52e-04	5	116	2	EFO_0008227
Disease	narcolepsy (is_implicated_in)	HLA-DQA1 CHKB	3.18e-04	7	116	2	DOID:8986 (is_implicated_in)
Disease	interleukin-21 measurement	HLA-DQA1 C1S	4.22e-04	8	116	2	EFO_0801724
Disease	lymphoid leukemia	NPR2 HLA-DQA1 ACOXL	4.52e-04	38	116	3	EFO_0004289
Disease	visceral leishmaniasis (is_implicated_in)	HLA-DQA1 TNF	5.42e-04	9	116	2	DOID:9146 (is_implicated_in)
Disease	Asthma, Occupational	TENM3 TNF	6.75e-04	10	116	2	C0264423
Disease	Jeune thoracic dystrophy	DYNC2H1 WDR19	8.23e-04	11	116	2	C0265275
Disease	Renal dysplasia and retinal aplasia (disorder)	CEP164 WDR19	9.86e-04	12	116	2	C0403553
Disease	autoimmune thyroiditis (is_implicated_in)	ZFAT HLA-DQA1	9.86e-04	12	116	2	DOID:7188 (is_implicated_in)
Disease	Leishmaniasis, Visceral	HLA-DQA1 TNF	1.16e-03	13	116	2	C0023290
Disease	aplastic anemia (is_implicated_in)	HLA-DQA1 TNF	1.16e-03	13	116	2	DOID:12449 (is_implicated_in)
Disease	oral cavity cancer	HLA-DQA1 TNF	1.35e-03	14	116	2	EFO_0005570
Disease	matrix metalloproteinase 1 measurement	MMP20 PRIM1	1.56e-03	15	116	2	EFO_0010588
Disease	Churg-Strauss syndrome	HLA-DQA1 ACOXL	1.56e-03	15	116	2	EFO_0007208
Disease	systemic lupus erythematosus, COVID-19	HLA-DQA1 BTN3A1 NXPE3	1.56e-03	58	116	3	MONDO_0007915, MONDO_0100096
Disease	lymphocyte count	IPPK ZFAT HLA-DQA1 FLVCR1 PSMB11 MED13L BCR PEBP4 TNF SSH2 DMBT1 SETD3 APBB1IP ACOXL	1.84e-03	1464	116	14	EFO_0004587
Disease	osteoarthritis	LCT SLC2A2 PKP2 SENP6 ALPK2	1.88e-03	222	116	5	MONDO_0005178
Disease	Child Behaviour Checklist assessment	PEBP4 TENM3	2.25e-03	18	116	2	EFO_0005661
Disease	tropical spastic paraparesis	HLA-DQA1 BTN2A1	2.25e-03	18	116	2	EFO_0007527
Disease	Sjogren's syndrome (is_implicated_in)	HLA-DQA1 TNF	2.25e-03	18	116	2	DOID:12894 (is_implicated_in)
Disease	monocyte percentage of leukocytes	CRYBG2 RPN1 HLA-DQA1 MED13L BPI SSH2 APBB1IP ACOXL BAHCC1	2.42e-03	731	116	9	EFO_0007989
Disease	polymyositis	SDK2 HLA-DQA1	2.78e-03	20	116	2	EFO_0003063
Disease	unipolar depression	CATSPERD DYNC2H1 MYO10 HLA-DQA1 BTN3A1 BTN2A1 NBAS PIEZO2 PKHD1 ASTN1 ACOXL EPHA7	2.84e-03	1206	116	12	EFO_0003761
Disease	epilepsy (biomarker_via_orthology)	GRIA1 TNF	3.06e-03	21	116	2	DOID:1826 (biomarker_via_orthology)
Disease	chronic myeloid leukemia (is_implicated_in)	HLA-DQA1 BCR	3.06e-03	21	116	2	DOID:8552 (is_implicated_in)
Disease	systemising measurement	DSCAM NBAS	3.06e-03	21	116	2	EFO_0010221
Disease	neuroimaging measurement	MYH10 HLA-DQA1 FAT3 BCR ITIH5 NELL2 PKHD1 PDXDC2P SSH2 SETD3 BAHCC1	3.30e-03	1069	116	11	EFO_0004346
Disease	portal hypertension (biomarker_via_orthology)	VASH1 TNF	3.36e-03	22	116	2	DOID:10762 (biomarker_via_orthology)
Disease	interleukin 10 measurement	DSCAM DYNC2H1 PDIA5	3.63e-03	78	116	3	EFO_0004750
Disease	arginine measurement	VIT PRIM1	3.67e-03	23	116	2	EFO_0020990
Disease	small cell lung carcinoma	DYNC2H1 HLA-DQA1 BTN3A1	3.90e-03	80	116	3	EFO_0000702
Disease	Asthma	HLA-DQA1 PPP2CA TNF	3.90e-03	80	116	3	C0004096
Disease	myeloid white cell count	IPPK MYO1E RPN1 HLA-DQA1 LCT BPI ATP6V0D2 SSH2 APBB1IP ACOXL	3.92e-03	937	116	10	EFO_0007988

Protein segments in the cluster

Peptide	Gene	Start	Entry
YNLGDIFLGVEYIFH	YBEY	86	P58557
LQYDGFKTVYFGETN	C21orf140	36	B9A014
GQHRFYGTQKDNFYL	BAHCC1	151	Q9P281
YGVYVINQHGEDTFN	B4GALT2	176	O60909
IQYPQFFGHSYVTFE	EGFLAM	386	Q63HQ2
ANQIIFGHNGFYVFY	CATSPERD	676	Q86XM0
FGHNGFYVFYISIVD	CATSPERD	681	Q86XM0
GQVTLAEFQDYYSGV	CAPS	241	Q13938
GVFLDYETGDISFYN	BTN3A1	461	O00481
VTQFGLYYEGNFHLN	ALS2	1191	Q96Q42
SQLGVYRAFVDNYGV	BCR	586	P11274
GIISNYEFFENQYIH	ALPK2	56	Q86TB3
IFEYYVGFTLFQTHD	CLK2	371	P49760
FIQFENVNIYYGTQH	APBB1IP	356	Q7Z5R6
QRENLTNGDYVFFYL	NPR2	241	P20594
IEFGYLDYAQSRFQF	CHKB	366	Q9Y259
GQYTHEFDGDEQFYV	HLA-DQA1	46	P01909
GNHYIQEAIYGFEES	ASTN1	861	O14525
YGNYAAVFAQLIIDG	ACOXL	136	Q9NUZ1
NFFQGYQYATEDGLI	ESRP1	651	Q6NXG1
SIQIENGYFVHYFAP	ITIH4	251	Q14624
YGHGVVQYFNVASAI	RBM45	286	Q8IUH3
FLGENYVHYGEVVQL	IPPK	66	Q9H8X2
HFYGVSNLQEFRYGL	ADIPOR1	351	Q96A54
FGYDDELYVSGQQQF	PRAMEF17	241	Q5VTA0
FGEASQKYNVLFVGY	MED13L	1816	Q71F56
FQGRTYFEGERNTVY	NELL2	336	Q99435
QQGLFIDGHFYNRIY	GMEB1	41	Q9Y692
GDIQVLNGYFVHYFA	ITIH5	271	Q86UX2
QQRYSFDGDYGALFQ	LRFN1	701	Q9P244
FYTVYHFNVGTEVVF	EFHC2	146	Q5JST6
HFNVGTEVVFYGRTF	EFHC2	151	Q5JST6
DIGYNFLVGQDGAIY	PGLYRP4	271	Q96LB8
GFHRYQFFVYLQEGK	PEBP4	146	Q96S96
SQYEDFVVDGFSGLY	PDXDC2P	156	Q6P474
HVAQQFSGINGIFYY	SLC2A2	311	P11168
DAIGYEGFQQFLKIY	DGKA	46	P23743
VNNFGVKHYAGEVQY	MYO10	541	Q9HD67
NGYTVKFGLYHVDFN	LCT	1326	P09848
FYVYSDGTRLQGDIF	PSMB11	161	A5LHX3
GNHESRQITQVYGFY	PPP2CB	116	P62714
GNHESRQITQVYGFY	PPP2CA	116	P67775
GVFQFKVDYNRLGYT	DDOST	386	P39656
YVFQIRAFTAAGYGN	EPHA7	511	Q15375
IGGFDHERLQYYFTL	NBAS	1751	A2RRP1
FQLEGYTAHFLQAGY	CASKIN2	501	Q8WXE0
NYGGVIKNYFQHREF	PRIM1	31	P49642
SDFVRYHYNGTFLDG	FKBP9	166	O95302
DHFGEEGVRYYFILN	DNAJC5G	106	Q8N7S2
AFLQQVLTYQGFYDE	DYNC2H1	2376	Q8NCM8
QGFSGDYSEYFGLQV	GBE1	371	Q04446
VQDGDFVRYHYNGTL	FKBP10	171	Q96AY3
YGTGVFGQNEYLRYQ	C1orf43	166	Q9BWL3
DYFFNTAGLVYQEAG	BPI	291	P17213
DAQAFGENRFYYTAG	CLDN11	181	O75508
VAYQEVGFSGEQYVL	CRYBG2	1306	Q8N1P7
NGEVTYVLQDDYGHF	FAT3	2116	Q8TDW7
NEERFTGFAAYYVAT	C1S	116	P09871
GVFLDYEAGDVSFYN	BTN2A1	451	Q7KYR7
IQYSIISNVFEGFYG	FLVCR1	126	Q9Y5Y0
GDTFLYGAQTVYRNF	GEN1	156	Q17RS7
FNYGFEYLGVQDKLV	DYNC1H1	1866	Q14204
YQRGFNVHALIEFGY	FAM111B	671	Q6SJ93
GVYAIFGFYERRTVN	GRIA1	81	P42261
QTFGGVNYFFDVEVG	CST4	76	P01036
EEVQYGNFDVNISFY	DMBT1	2246	Q9UGM3
RAIYFDGDFGQIVRY	GFM1	221	Q96RP9
HVSFRDFEYALNYGQ	EFCAB11	146	Q9BUY7
YDFRVIAVNDYGFGT	SDK2	1896	Q58EX2
LEGFNNYRFLSNGYI	MYH10	301	P35580
GRFLFQYDNYGSTAE	PDIA5	236	Q14554
GQIDAAVELNGYIYF	MMP20	441	O60882
QIGYREYSTGGNFQF	DSCAM	1021	O60469
VYFQYVGTDFNGVAA	PUSL1	16	Q8N0Z8
LDYEAGVVSFYNGNT	TRIM38	416	O00635
QQHNRGGYFLVDFYA	MRPS6	56	P82932
VVDYQNGFYKVFFTL	NXPE3	161	Q969Y0
GLFTFYHEGYELAQE	ARHGAP42	206	A6NI28
VFTGYIENNYQHSIF	PTCHD1	426	Q96NR3
YDFDVFVVRGAGAYI	NDUFV1	191	P49821
LYEVALVTQGGFDYA	PTCH2	736	Q9Y6C5
KQFVVFEGNHYFYSP	RPN1	151	P04843
EDFYVTQAYQGLGIG	SATL1	616	Q86VE3
QDFRAGEQIYIFYGT	SETD3	301	Q86TU7
DFLIYGTDTGVVQYF	WDR19	486	Q8NEZ3
HEGLYFLEAYFGGQL	PKHD1	101	P08F94
TYGLYFCGNFEINHF	OR5M9	161	Q8NGP3
FYRYGENNSLSVEGF	SLC39A6	61	Q13433
YHSFGVTENYVIFLE	BCO1	236	Q9HAY6
QDITGDIYYFNFANG	CEP164	66	Q9UPV0
IRGLQFASFIVQYYG	PRPF8	1031	Q6P2Q9
AFEFTYVNVYGTHVL	TGDS	111	O95455
EVHDFKNGYTGIYFV	TNMD	101	Q9H2S6
YTQGGEASEFIVYVQ	ZFAT	1211	Q9P243
VYNEGRATFNHVSYG	ZNF287	341	Q9HBT7
NFFPGVFEYHNIRVY	SSH2	346	Q76I76
TVYVDFQYFDGANGT	THSD1	41	Q9NS62
GHLIGLYLYQFQFFQ	PIEZO2	281	Q9H5I5
HFGSVQVYLNFGVFY	TMED6	126	Q8WW62
AVQYTYEQRLEFGFD	VIT	536	Q6UXI7
AIVFVVGGGNYIEYQ	SCFD1	591	Q8WVM8
AFTADGDQVFAGRYY	SMC6	636	Q96SB8
GVYVLQYVESFFENP	SENP6	1031	Q9GZR1
FGKFGVIYYDINQII	TENM3	2056	Q9P273
HLIQAIFQGYFAYSG	SLC7A13	206	Q8TCU3
AQNVGGEEFYFVYQS	PKHD1L1	1141	Q86WI1
GEEFYFVYQSQISHI	PKHD1L1	1146	Q86WI1
YHRGDIFENVDYVQF	TTC17	431	Q96AE7
FLFVASEFGNHYLYQ	SF3B3	346	Q15393
VFLTGFGYVYVDVVH	VPS13B	3341	Q7Z7G8
SYVNFGVFRLYGDDA	XPO7	846	Q9UIA9
LHRYYFEVEIFGAGT	TRIM16	426	O95361
NIYNTLSGLVEFDGY	UBR4	3511	Q5T4S7
YFSGNYFRHIVLGVN	VASH1	196	Q7L8A9
YVYNLHLVENDFVGG	PKP2	86	Q99959
FYDDHFQGYLVTQAV	XYLT2	596	Q9H1B5
DYLDFAESGQVYFGI	TNF	216	P01375
FYGHYTIDGVKFQNF	TMC7	246	Q7Z402
GNKVLYETYHGVFVN	VPS26C	101	O14972
NVLAFNRQFHYGVFY	ATP6V0D2	301	Q8N8Y2
EYNIGVLDIYGFEIF	MYO1E	381	Q12965
YVVFNNGTLYFNEVG	MXRA5	2301	Q9NR99
ETQFGINHFAGIVYY	MYO7A	546	Q13402
INHFAGIVYYETQGF	MYO7A	551	Q13402
IAHFAGEVYYQAEGF	MYO7B	551	Q6PIF6